Key result
Mitral valve prolapse-related regurgitation affects ~15 million globally and leads mitral intervention indications in high-income countries.
Why the study?
Although degenerative mitral valve regurgitation due to mitral valve prolapse affects approximately 15 million people globally and is the commonest indication for mitral intervention in high-income countries, its biology, natural history, and lifetime management remain ill defined.
Answers are grounded in this paper and cite their sources.
This review summarizes the current knowledge, areas of uncertainty, and emerging research directions in the epidemiology, pathophysiology, risk stratification, and surgical versus transcatheter management of degenerative mitral regurgitation.
Degenerative mitral valve regurgitation due to mitral valve prolapse affects ≈15 million people globally and is the commonest indication for mitral intervention in high-income countries, but its biology, natural history, and lifetime management are ill defined. This review summarizes current knowledge of the epidemiology, pathophysiology, diagnosis, risk stratification, and lifetime management of degenerative mitral regurgitation, with a focus on areas of uncertainty, recent advances, and emerging research directions. These include translational research focused on determining genetic and cellular drivers of disease progression and mechanistic studies geared to improve detection and prevention of downstream myocardial dysfunction, particularly in high-risk phenotypes, including arrhythmic mitral prolapse. The current landscape of randomized trials and large registries comparing contemporary surgical and transcatheter treatment and strategies to improve patient access to care and outcomes across all patient risk profiles and populations are also discussed.
No takes yet. Share an insight, caveat, or question.
Chikwe et al. (2026) conducted a review in Degenerative mitral valve regurgitation due to mitral valve prolapse. Surgical and transcatheter mitral valve interventions was evaluated. Degenerative mitral regurgitation due to mitral valve prolapse affects ≈15 million people globally and is the leading indication for mitral intervention in high-income countries.
Synapse has enriched 10 related papers. Consider them for comparative context: